Dal Spin-Off Poised To Sell Protein Device
October 25th, 2013
“I can get rid of these contaminations at the push of a button,” Alan Doucette, the chairman of BIKE’s science advisory board, said at the BioInnovation Challenge. “It works every time if you do it right.”
In 2009, Doucette told Kevin Buchan of Dalhousie’s industry liaison and innovation office about his plan for a new product, whose capsules would isolate proteins. They worked together to secure early funding from Springboard Atlantic and Innovacorp’s Early Stage Commercialization Fund to begin the process of innovating and testing the prototype. The technology was then out-licensed to BIKE.